Powder -80℃ 2 years; -20℃ 1 year In solvent -80℃ 6 months; -20℃ 1 month（Protect from light）
研究领域：
Metabolic Disease; Cardiovascular Disease
描述：
ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis. ATWLPPR Peptide TFA has potential in reducing
m.cnreagent.com
